Ophthalmology-2014 is designed to offer comprehensive sessions that addresses current issues of Ophthalmic Accession and Scientific Intelligence
Los Angeles, CA (PRWEB) April 29, 2014
The conference brings together a unique and international melange of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions, making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.
Ophthalmology-2014 will provide a momentous platform for scientists, Ophthalmic Researchers, Professors and students to meet and share their knowledge. It will be an opportunity to foster collaborations through research talks and presentations.
Speakers from all over the world are going to join their peers at OMICS Group International conference on Ophthalmology. Reputed speakers include Chi-Chao Chan, National Institutes of Health, who will be sharing her experience related to “Inflammasomes in age-related macular degeneration”. Michael L Nickerson, National Institutes of Health along with his group of 10 members will be conducting a special session on "Schnyder Corneal Dystrophy and UBIAD1 function". Another special session which is going to be a part of this conference includes, Timothy J McCauley’s from The Wilmer Eye Institute.
Other peerless speakers that are part of the Ophthalmology -2014 includes Michael Dean, National Cancer Institute at Frederick, USA who will be expressing views on “Insights into eye diseases and biology using genetics” whereas Xueting Jin, National Health of Institutes, USA will be giving an insight on “Schnyder Corneal Dystrophy - abnormal cholesterol homeostasis in a connective tissue”, Kerry Goetz, National Eye Institute, USA will be presenting a speech on “The national ophthalmic genotyping and phenotyping network (eyegene®): preserving vision through genetics” & Eugenia Poliakov, National Eye Institute, USA will confabulate on “Long-term multiple A2E treatment leads to melanization of ARPE19 cells.”
Several workshops will be conducted in this pragmatic conference by various eminent personalities like Carlota Saldanha, Institute of Biochemistry, Portugal on “Repercussions in Eye Microcirculation of Patients with Systemic Vascular Disease” and A Umur Kayabasion “Different Optic Neuropathies and Novel Treatments” from World Eye Hospital, Turkey..
Ashim K Mitra, University of Missouri-Kansas City’s special symposium, “Emerging Technologies in Controlled Long Term Delivery of Ocular Therapeutics” is added to magniloquent Ophthalmology-2014.
With DXDT Engineering sponsoring the programme, Ophthalmology-2014 is collaborating with the speakers through prestigious companies like Pfizer Pharmaceuticals, USA, Allergan Inc., USA, Advantar Laboratories, Inc., USA, Family Eye Group, USA, Trevithick Surgery, UK & BioPharm Physician, USA.
OMICS Publishing Group hosts 350 Open Access Journals and conducts more than 100 International conferences worldwide every year with support from 30,000 strong editorial board members drawn from academics, research and industries. OMICS Group Journal of Clinical & Experimental Ophthalmology will publish the accepted papers presented in Ophthalmology- 2014.
Please contact for more information related to the conference:
5716 Corsa Ave, Suite110
Westlake, Los Angeles
Office Ph: +1-650-268-9744
Toll No +1-800-216-6499(USA & Canada)